Posted in | News | Nanobusiness

Nanostart Asia Announces Sale of Shares in Curiox Biosystems

Nanostart Asia, a subsidiary of Nanostart AG (OTCQX:NASRY), has announced the sale of its ownership stake in Curiox Biosystems Pte Ltd – held through the Nanostart Singapore Early Stage Venture Fund – to a strategic investor, the Zicom Group. An undisclosed profit was achieved with the sale.

The sale of shares took place within the framework of a Curiox capital increase, in which the Zicom Group simultaneously took control of the Nanostart Asia share in Curiox. As a new strategic investor in Curiox, Zicom will own nearly 41 percent of shares.

"We already decided at a relatively early stage to sell our share in Curiox to the Zicom Group, an investor with a strategic interest. We remain convinced of the developmental potential of Curiox," explains Andreas Kröll, managing director of Nanostart Asia. "We carefully compared the additional financial costs and our earnings forecast for invested capital with our overall earnings goals."

Sales proceeds received by Nanostart for its shares in Curiox will not be distributed as dividends and therefore will not impact results at the Nanostart AG level. Instead they will flow back into the fund and be invested in new shareholdings.

In 2007, Curiox Biosystems was the first shareholding financed by Nanostart AG in Singapore. Curiox has developed a process for analyzing aqueous bioprobes that requires only a fraction – an average of one hundredth – of the usually required testing quantity.

The Nanostart Singapore Early Stage Venture Fund I was the first private investment fund to be launched by Nanostart AG as a segregated vehicle, a structure typical in the venture capital industry. The government of Singapore has, through its National Research Foundation (NRF), invested SGD 10 million (approx. EUR 5 million) in this fund dedicated to bringing the most promising nanotechnology-based startups in Singapore to successful commercialization. The fund is managed by Nanostart Asia Pte Ltd, a 100% subsidiary of Nanostart AG.

The acquiring company, Zicom Group, is a leading specialist equipment manufacturer and niche engineering service provider with core expertise in mechanical, hydraulics, precision, and instrumentation engineering.

Source: http://www.nanostart.de/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Coreo AG. (2019, February 13). Nanostart Asia Announces Sale of Shares in Curiox Biosystems. AZoNano. Retrieved on November 22, 2024 from https://www.azonano.com/news.aspx?newsID=21063.

  • MLA

    Coreo AG. "Nanostart Asia Announces Sale of Shares in Curiox Biosystems". AZoNano. 22 November 2024. <https://www.azonano.com/news.aspx?newsID=21063>.

  • Chicago

    Coreo AG. "Nanostart Asia Announces Sale of Shares in Curiox Biosystems". AZoNano. https://www.azonano.com/news.aspx?newsID=21063. (accessed November 22, 2024).

  • Harvard

    Coreo AG. 2019. Nanostart Asia Announces Sale of Shares in Curiox Biosystems. AZoNano, viewed 22 November 2024, https://www.azonano.com/news.aspx?newsID=21063.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.